Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prospective Study on Effects of Sports Participation on Brain Injury versus Orthopedic Injury in the Adolescent Brain Cognitive Development Study.

Journal of neurotrauma·2026
Same author

Early experience with a patient-facing AI chatbot integrated in a patient portal.

JAMIA open·2026
Same author

Novel Psychiatric Disorders Following Mild Traumatic Brain Injury in the Second Year of the Adolescent Brain Cognitive Development Study.

Journal of neurotrauma·2026
Same author

MEG Working Memory N-Back Task Revealed Functional Deficits in Children with Mild Traumatic Brain Injury.

Journal of neurotrauma·2026
Same author

Metalloproteinase imbalance in HIV-1: Subtype comparison in CSF and serum.

Journal of neuroimmunology·2026
Same author

Multi-tissue multi-omics integration reveals tissue-specific pathways, gene networks and drug candidates for type 1 diabetes.

Diabetologia·2026

Related Experiment Video

Updated: Jun 24, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

Random changepoint modelling of HIV immunologic responses.

Pulak Ghosh1, Florin Vaida

  • 1Department of Mathematics and Statistics, Georgia State University, Atlanta, GA 30303-3083, USA. pghosh@mathstat.gsu.edu

Statistics in Medicine
|September 14, 2006
PubMed
Summary

This study introduces a changepoint model to analyze CD4 T-cell counts in HIV patients on antiretroviral therapy. The model captures individual changes and informative censoring, improving HIV treatment analysis.

More Related Videos

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

Related Experiment Videos

Last Updated: Jun 24, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

Area of Science:

  • Biostatistics
  • Immunology
  • Epidemiology

Background:

  • Longitudinal CD4 T-cell counts are crucial for monitoring HIV disease progression and treatment efficacy.
  • Highly active antiretroviral therapy (HAART) has transformed HIV management, necessitating robust analytical methods for patient data.
  • Informative censoring due to treatment discontinuation or study withdrawal can bias longitudinal data analysis.

Purpose of the Study:

  • To propose a novel changepoint model for analyzing longitudinal CD4 T-cell counts in HIV-infected individuals undergoing HAART.
  • To incorporate subject-specific random parameters, including the changepoint, into the CD4 count model.
  • To jointly model CD4 count trajectories and informative drop-out mechanisms.

Main Methods:

  • A 'broken stick' changepoint model was developed to represent individual CD4 count profiles.
  • Baseline covariates were included to account for their influence on CD4 counts.
  • A joint model for CD4 counts and informative censoring (drop-out) was implemented using a Bayesian framework.
  • Markov chain Monte Carlo (MCMC) methods were utilized for parameter estimation via WinBUGS software.

Main Results:

  • The proposed model effectively captures individual variability in CD4 T-cell count trajectories.
  • The joint modeling approach successfully addresses informative censoring, providing less biased estimates.
  • Model selection criteria (DIC) favored the complex model with random changepoints and informative censoring.

Conclusions:

  • The developed changepoint model provides a flexible and accurate tool for analyzing longitudinal CD4 data in HIV patients.
  • Jointly modeling CD4 counts and drop-out mechanisms is essential for robust analysis in the presence of informative censoring.
  • The findings support the utility of advanced statistical modeling in understanding HIV treatment dynamics and improving patient outcomes.